Aurora Cannabis Inc. (ACB.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 7.32 |
| Open | 7.30 |
| Bid | 7.50 x 0 |
| Ask | 7.54 x 0 |
| Day's Range | 7.26 - 7.64 |
| 52 Week Range | 3.84 - 12.85 |
| Volume | |
| Avg. Volume | 718,757 |
| Market Cap | 412.142M |
| Beta (5Y Monthly) | 2.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.50 |
ZacksACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
- Baystreet
Stocks in play: Aurora Cannabis Inc.
Announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia ...
PR NewswireAurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie
© 2024 Yahoo. All rights reserved.